FMS
Fresenius Medical·NYSE
--
--(--)
--
--(--)
FMS Filings
Filing Date
Form Description
Form Type
2026-03-18
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-03-18 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-02-24
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-24 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-02-24
Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).
2026-02-24 ·
Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).
2026-02-24
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Financials
2026-02-24 · Financials
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026-02-24
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2026-02-24 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-12
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-12 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-09
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-01-09 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-12-10
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-10 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-17
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-17 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-04
Fresenius Medical Care AG (FMS) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-04 · Earnings Call
Fresenius Medical Care AG (FMS) Q3 2025 Earnings Call Transcript
